Exalenz Bioscience - Articles and news items

Exalenz Bioscience launches clinical study for breath-based detection of primary liver cancer

Industry news / 4 June 2015 / Victoria White

Exalenz Bioscience has initiated a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+